ATRIAL FIBRILLATION TREATMENT PARADOX: CHARACTERISTICS OF AND FIRST-YEAR EVENTS IN PATIENTS NOT TREATED WITH VITAMIN-K ANTAGONISTS COMPARED TO TREATED PATIENTS. THE GARFIELD REGISTRY

 A large proportion of atrial fibrillation (AF) patients do not receive guideline-recommended thromboprophylaxis, leaving them at risk for stroke and death. Using data from the 1st cohort of the prospective GARFIELD Registry, we characterized factors associated with non-use of vitamin K antagonists (VKA) for stroke prevention in AF. Read more